Brief: India's Wanbury expects no material impact from Thane FDA notice
08/11/2016 14:11
Nov 8 (Reuters) - Wanbury Ltd WANB.NS
* India's Wanbury says show cause notice from Thane FDA does
not have material impact on operations
Further company coverage: WANB.NS
Recent news on Wanbury
See all newsBrief: Wanbury Ltd Receives 9 “No DMF Deficiency” Letters From USFDA For Metformin HCl
Brief: Wanbury Files New Drug Master File In South Africa For Tramadol Hcl API
Brief: Wanbury June-Quarter PAT 32.4 Million Rupees
Brief: Wanbury Receives No DMF Deficiency Letter From USFDA For Multiple Andas
Brief: Wanbury Says Completion Of US FDA Inspection At Tanuku Facility